Abeona Therapeutics Inc. (ABEO)

NASDAQ: ABEO · IEX Real-Time Price · USD
5.01
-0.13 (-2.53%)
At close: Dec 29, 2023, 4:00 PM
4.93
-0.08 (-1.60%)
After-hours: Dec 29, 2023, 7:45 PM EST

Abeona Therapeutics Revenue

Abeona Therapeutics had revenue of $3.57M in the twelve months ending September 30, 2023, down -17.90% year-over-year. In the year 2022, Abeona Therapeutics had annual revenue of $1.41M, a decrease of -52.87%.

Revenue (ttm)
$3.57M
Revenue Growth
-17.90%
P/S Ratio
34.79
Revenue / Employee
$62,596
Employees
57
Market Cap
124.11M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20221.41M-1.59M
-52.87%
Dec 31, 20213.00M-7.00M
-70.00%
Dec 31, 202010.00M--
Dec 31, 20190--
Dec 31, 20183.00M2.16M
258.18%
Dec 31, 2017837.00K-52.00K
-5.85%
Dec 31, 2016889.00K-151.00K
-14.52%
Dec 31, 20151.04M115.00K
12.43%
Dec 31, 2014925.00K-1.12M
-54.70%
Dec 31, 20132.04M-2.36M
-53.63%
Dec 31, 20124.40M2.54M
135.63%
Dec 31, 20111.87M1.34M
251.98%
Dec 31, 2010531.00K179.00K
50.85%
Dec 31, 2009352.00K61.00K
20.96%
Dec 31, 2008291.00K234.00K
410.53%
Dec 31, 200757.00K--
Dec 31, 20060--
Dec 31, 20050--
Dec 31, 20040--
Dec 31, 20030--
Dec 31, 20021.15M904.00K
372.02%
Dec 31, 2001243.00K136.00K
127.10%
Dec 31, 2000107.00K92.00K
613.33%
Dec 31, 199915.00K--
Dec 31, 19980--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
111, Inc. 2.06B
Emergent BioSolutions 1.10B
High Tide 468.81M
Inogen 327.86M
FONAR 101.29M
Seer, Inc. 16.83M
Sagimet Biosciences 2.00M
Revenue Rankings